New COVID-19 drug shows greater promise against resistant viral strains
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...
NC Biotech2d
FDA clears Precision BioSciences to begin trials of gene-editing treatment for hepatitis B
Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...
Genetic Heart Disease: Can this investigational drug treat the incurable?
Inherited or genetic heart disorders, mostly known as Hypertrophic cardiomyopathy (HCM) in medical term, is a condition ...
Nasdaq1mon
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
today announced the submission of its Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a phase 2 clinical trial in ALS. This pivotal step marks a ...
CURE9d
New Cancer Vaccine, EVM14, Cleared for Investigational Drug Application
EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...
Morningstar16d
Altesa BioSciences Announces Clearance of Investigational New Drug (IND) Application for Vapendavir
today announced that the U.S. Food and Drug Administration (FDA) has cleared Altesa's new Investigational New Drug (IND) application for vapendavir for the treatment of rhinovirus infections in ...
Seeking Alpha4d
CERo Therapeutics Holdings, Inc. Receives FDA Clearance of Second Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Lead Compound CER-1236 in Solid Tumors
announces that the Company has received clearance by the U.S. Food and Drug Administration (FDA) for a second Investigational New Drug (IND) application for lead compound CER-1236 for a Phase 1 ...
Enid News & Eagle11d
Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA ...
today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for VERVE-102 for the treatment of patients living with heterozygous ...
The Manila Times2d
Biogen's Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer's Disease
"We are encouraged by the FDA's Fast Track designation for BIIB080, which highlights the urgent need for innovative ...
Medscape2d
Using Preprinted Medication Order Forms to Improve the Safety of Investigational Drug Use
Am J Health Syst Pharm. 2006;63(11):1022-1028. Q: How can potential medication errors be minimized when dispensing investigational drugs to better ensure patient safety and improve adherence to ...
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
Yahoo Finance16d
Altesa BioSciences Announces Clearance of Investigational New Drug (IND) Application for Vapendavir
"The new IND allows us to advance our studies in COPD, already ongoing in the United Kingdom, into the United States." Altesa already has an open IND for vapendavir to treat rhinovirus infections ...